Suchergebnisse - "Tuyaerts, Sandra"

PubPharm (75)

1

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

enthalten in: Journal for immunotherapy of cancer | 2024

von Tijtgat, J. | Geeraerts, X. | Boisson, A. | +10

2

Current "state of the art" on dendritic cell-based cancer vaccines in melanoma

enthalten in: Current opinion in oncology | 2023

von Schwarze, J. | Geeraerts, X. | Tuyaerts, S. | +1

3

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : Results of the phase II PRIMMO study

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von De Jaeghere, E. | Tuyaerts, S. | Van Nuffel, A. | +18

4

Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives

enthalten in: Frontiers in immunology | 2023

von Duerinck, J. | Tuyaerts, S. | Movahedi, K. | +1

5

Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients : a phase I clinical trial

enthalten in: Journal for immunotherapy of cancer | 2022

von Schwarze, J. | Tijtgat, J. | Awada, G. | +8

6

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

enthalten in: Cancer immunology immunotherapy | 2022

von De Jaeghere, E. | Tuyaerts, S. | Van Nuffel, A. | +18

7

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

enthalten in: Cancer immunology immunotherapy | 2022

von De Jaeghere, E. | Tuyaerts, S. | Van Nuffel, A. | +18

8

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study

enthalten in: Cancer immunology immunotherapy | 2022

von De Jaeghere, E. | Tuyaerts, S. | Van Nuffel, A. | +18

9

Trial watch : Dendritic cell (DC)-based immunotherapy for cancer

enthalten in: Oncoimmunology | 2022

von Laureano, R. | Sprooten, J. | Vanmeerbeerk, I. | +22

10

Endometrial Cancer Molecular Characterization : The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?

enthalten in: Cancers | 2021

von Baiden-Amissah, R. | Annibali, D. | Tuyaerts, S. | +1

1
2
3
4
5
6
7
8
Nächster »
[8]